New drug for heart disease shows promise for cats and humans

December 22, 2016 by Rob Warren
UC Davis veterinary cardiologist Joshua Stern performs an echocardiogram on a cat, assisted by animal health technicians Heather Schrader, right, and Judy Schettler. Credit: Don Preisler/UC Davis

A new drug shows promise for treating heart disease in cats and humans, according to research by a team including veterinarians at the University of California, Davis, School of Veterinary Medicine.

The novel drug, MYK-461, proved effective in a study of five cats with a naturally occurring form of inherited hypertrophic cardiomyopathy (HCM), a currently incurable disease that also affects humans. A paper describing the work was published Dec. 14 in the journal PLOS ONE.

HCM is the most common form of feline heart disease and results in thickening of the walls of the heart ventricles and altering of heart function. It frequently leads to fatal consequences. Cats with this disease may suffer , and sudden death. In humans, HCM is a frequent cause of that can even afflict seemingly healthy young athletes.

HCM affects approximately one in 500 people and was recently reported to affect a startling one in seven cats. More than 1,500 genetic mutations have been associated with the disease in humans, creating challenges for researchers. However, veterinary scientists are making strides in identifying the best treatment options for the disease since the cat condition and human condition are so similar.

In the study, treatment with MYK-461 eliminated left ventricular obstruction in five cats with HCM. The is the first in its class and uniquely addresses the functional changes that are seen in and feline HCM.

"This is an exciting discovery for both animals and humans – an excellent representation of the One Health concept in action," said Associate Professor Joshua Stern, chief of the Cardiology Service at the UC Davis veterinary hospital. "The positive result in these five cats shows that MYK-461 is viable for use in cats as a possible option to halt or slow the progression of HCM."

MYK-461 was already shown to stop the thickening of the ventricle walls in mice.

Current treatment for cats with HCM is largely symptomatic. There is no preventative therapy for HCM that is shown to change the course of .

"There has been little to no progress in advancing the treatment of HCM in humans or animals for many years," Stern said. "This study brings new hope for cats and people."

With this proof of concept that the drug is viable for use in cats, UC Davis hopes to conduct a clinical trial in the near future, which could determine if MYK-461 has the potential to become the accepted protocol for care of with HCM.

Explore further: Researchers study stem-cell therapy for feline kidney disease

More information: Joshua A. Stern et al. A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy, PLOS ONE (2016). DOI: 10.1371/journal.pone.0168407

E. M. Green et al. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice, Science (2016). DOI: 10.1126/science.aad3456

Related Stories

Researchers study stem-cell therapy for feline kidney disease

January 9, 2014
Chronic kidney disease in older cats is the focus of a fifth clinical trial under way at Colorado State University's James L. Voss Veterinary Teaching Hospital, where veterinarians are exploring novel stem-cell therapy that ...

Cat stem cell therapy gives humans hope

February 2, 2016
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Afflicted with a painful oral inflammatory disorder, Bob had already lost all of his teeth in an effort to treat the ...

Chronic kidney disease in cats—Expert guidance on a quality of life issue

March 2, 2016
Chronic kidney disease (CKD) is a common, complex and progressive disease that is estimated to affect more than a third of cats over 10 years of age. Affected cats often present with a variety of clinical signs and complications ...

Recommended for you

Laser device placed on the heart identifies insufficient oxygenation better than other measures

September 20, 2017
A new device can assess in real time whether the body's tissues are receiving enough oxygen and, placed on the heart, can predict cardiac arrest in critically ill heart patients, report researchers at Boston Children's Hospital ...

Metabolism switch signals end for healing hearts

September 19, 2017
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it.

Beta blockers not needed after heart attack if other medications taken

September 18, 2017
A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge ...

Which single behavior best prevents high blood pressure?

September 15, 2017
(HealthDay)—You probably already know that certain healthy lifestyle behaviors can reduce your risk of developing high blood pressure, but is any one behavior more important than the others?

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke

September 13, 2017
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial ...

Study shows so-called 'healthy obesity' is harmful to cardiovascular health

September 11, 2017
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities such as diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.